Agape ATP (ATPC) Competitors $1.55 -0.02 (-1.27%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$1.61 +0.06 (+3.87%) As of 08:03 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock ATPC vs. TOI, AIRS, VMD, XGN, DCGO, KDLY, EUDA, CORBF, BMGL, and QIPTShould you be buying Agape ATP stock or one of its competitors? The main competitors of Agape ATP include Oncology Institute (TOI), AirSculpt Technologies (AIRS), Viemed Healthcare (VMD), Exagen (XGN), DocGo (DCGO), Kindly MD (KDLY), EUDA Health (EUDA), Global Cord Blood (CORBF), Basel Medical Group (BMGL), and Quipt Home Medical (QIPT). These companies are all part of the "healthcare" industry. Agape ATP vs. Its Competitors Oncology Institute AirSculpt Technologies Viemed Healthcare Exagen DocGo Kindly MD EUDA Health Global Cord Blood Basel Medical Group Quipt Home Medical Oncology Institute (NASDAQ:TOI) and Agape ATP (NASDAQ:ATPC) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, community ranking, institutional ownership, valuation, earnings, risk, profitability and dividends. Does the media favor TOI or ATPC? In the previous week, Oncology Institute had 9 more articles in the media than Agape ATP. MarketBeat recorded 10 mentions for Oncology Institute and 1 mentions for Agape ATP. Agape ATP's average media sentiment score of 1.87 beat Oncology Institute's score of 0.49 indicating that Agape ATP is being referred to more favorably in the news media. Company Overall Sentiment Oncology Institute Neutral Agape ATP Very Positive Is TOI or ATPC more profitable? Oncology Institute has a net margin of -17.63% compared to Agape ATP's net margin of -194.09%. Agape ATP's return on equity of -74.71% beat Oncology Institute's return on equity.Company Net Margins Return on Equity Return on Assets Oncology Institute-17.63% -186.83% -34.58% Agape ATP -194.09%-74.71%-56.08% Which has more volatility & risk, TOI or ATPC? Oncology Institute has a beta of 0.13, indicating that its share price is 87% less volatile than the S&P 500. Comparatively, Agape ATP has a beta of -0.82, indicating that its share price is 182% less volatile than the S&P 500. Does the MarketBeat Community favor TOI or ATPC? Oncology Institute received 5 more outperform votes than Agape ATP when rated by MarketBeat users. Likewise, 71.43% of users gave Oncology Institute an outperform vote while only 0.00% of users gave Agape ATP an outperform vote. CompanyUnderperformOutperformOncology InstituteOutperform Votes571.43% Underperform Votes228.57% Agape ATPOutperform VotesNo VotesUnderperform Votes1100.00% Which has higher earnings & valuation, TOI or ATPC? Agape ATP has lower revenue, but higher earnings than Oncology Institute. Oncology Institute is trading at a lower price-to-earnings ratio than Agape ATP, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOncology Institute$403.15M0.63-$83.07M-$0.70-4.09Agape ATP$1.29M59.94-$2.10M-$0.60-2.58 Do insiders & institutionals have more ownership in TOI or ATPC? 36.9% of Oncology Institute shares are owned by institutional investors. Comparatively, 0.0% of Agape ATP shares are owned by institutional investors. 8.5% of Oncology Institute shares are owned by company insiders. Comparatively, 9.7% of Agape ATP shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Do analysts recommend TOI or ATPC? Oncology Institute currently has a consensus price target of $7.00, suggesting a potential upside of 144.76%. Given Oncology Institute's stronger consensus rating and higher probable upside, equities research analysts plainly believe Oncology Institute is more favorable than Agape ATP.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Oncology Institute 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Agape ATP 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryOncology Institute beats Agape ATP on 11 of the 18 factors compared between the two stocks. Get Agape ATP News Delivered to You Automatically Sign up to receive the latest news and ratings for ATPC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ATPC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ATPC vs. The Competition Export to ExcelMetricAgape ATPHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$77.51M$815.14M$5.57B$8.63BDividend YieldN/A2.29%5.28%4.18%P/E Ratio-2.1253.4227.1420.06Price / Sales59.948.14411.98157.10Price / CashN/A26.1438.2534.64Price / Book1.363.637.064.70Net Income-$2.10M-$5.50M$3.23B$247.88M7 Day Performance6.90%-2.21%2.85%2.63%1 Month Performance-6.06%-4.95%9.06%6.36%1 Year Performance-66.45%23.29%31.43%14.05% Agape ATP Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ATPCAgape ATP1.0757 of 5 stars$1.55-1.3%N/A-67.0%$77.51M$1.29M-2.1240TOIOncology Institute2.8906 of 5 stars$3.20-1.5%$7.00+118.8%+477.8%$285.55M$403.15M-4.10660Insider TradeHigh Trading VolumeAIRSAirSculpt Technologies0.7359 of 5 stars$4.63+3.8%$3.75-19.0%+20.2%$272.15M$172.10M-33.07240News CoverageVMDViemed Healthcare2.1047 of 5 stars$6.79+3.5%N/A-4.9%$268.37M$232.79M25.15630Positive NewsXGNExagen3.0976 of 5 stars$7.39+3.5%$7.50+1.5%+259.4%$157.41M$56.72M-7.86220News CoverageHigh Trading VolumeDCGODocGo3.2876 of 5 stars$1.48-0.7%$3.56+140.5%-52.6%$150.94M$520.50M5.292,920Positive NewsKDLYKindly MD0.6617 of 5 stars$21.29-5.8%N/A+314.3%$128.21M$2.47M-27.65N/AGap UpEUDAEUDA Health0.2743 of 5 stars$3.32-9.3%N/A+47.4%$123.35M$4.01M0.002Positive NewsGap DownCORBFGlobal Cord BloodN/A$1.00flatN/A+1.6%$121.55M$196.12M0.001,200BMGLBasel Medical GroupN/A$5.09+29.8%N/AN/A$93.94M$10.05M0.0036Gap UpHigh Trading VolumeQIPTQuipt Home Medical2.5377 of 5 stars$1.80+4.0%$2.85+58.3%-35.0%$77.56M$240.85M-10.59800Options Volume Related Companies and Tools Related Companies TOI Competitors AIRS Competitors VMD Competitors XGN Competitors DCGO Competitors KDLY Competitors EUDA Competitors CORBF Competitors BMGL Competitors QIPT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ATPC) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agape ATP Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Agape ATP With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ATPC Stock Free ATPC Stock Alerts